Webinar: Advances in Hormone Therapy

Wednesday, October 16 | 11am ET / 8am PT | Online

Discover how the latest advancements in hormone replacement therapy are set to revolutionize patient care.

At this webinar, attendees can expect to hear about:

The current standard of care in hormone replacement therapy
Innovative approaches to hormone therapy
How Likarda’s cutting-edge technology, originally developed for complex therapies, is being applied to improve hormone delivery
The potential Impact of Injectable Extended-Release Hormones

Access this on-demand recording today!

Meet the Speakers

Dr. Charles Virden, MD

CEO, VitalTE

Dr. Charles Virden attended Occidental College for his undergraduate years to earn a Bachelor of Applied Science (BASc) in biology. He went to medical school at the University of Southern California, Keck School of Medicine. In 1987, he graduated from the University of Southern California with a medical degree. Dr. Virden completed his general surgery internship and residency at the University of California, San Diego, CA in 1993. He also completed a research fellowship and residency in plastic surgery at the University of California in San Diego, CA. Dr. Virden moved to Reno, NV in 1995 to open his private practice.

He is the CEO of VitalTE, a company innovating the way people receive hormone therapy. He is a world renowned author in subcutaneous biomechanics and is a double Board Certified physician.

Dr. Stella Vnook

CEO, Likarda

Dr. Stella Vnook is a distinguished pharmaceutical executive, serial entrepreneur, highly respected CEO and founder of multiple biotech companies and visionary leader with a proven track record of success in the biotechnology and life sciences industries. With over 25 years of experience, Dr. Vnook has played a pivotal role in shaping the future of Companies, such as Merck and Co, Jazz Pharmaceuticals and Catalent, and small start-ups through her leadership, innovation, and commitment to advancing medical science.

Dr. Vnook’s journey in the biotech industry began with her groundbreaking research in molecular biology and drug discovery research at Temple School of Medicine Emergency Medicine. Vnook earning her a Doctorate in Public Health/ Healthcare Economics, as well as Degree in Pharmacy specializing in Pharmacology and Oncology, Master of Business Administration focusing in Global Marketing in addition to her portfolio of degrees in Biology, Anthropology and Mathematics. Her passion for translating scientific innovation into tangible therapeutic solutions led her to found her first biotech startup, MaiCell and later NAKI Therapeutics, where she served as CEO and Founder and Diverse Biotech BioSciences where she served as CEO.

As a CEO of Likarda, Vnook is poised to propel the company to new heights by leveraging her extensive experience and innovative vision. Under her leadership, Likarda aims to expand its presence in the biotech industry by pioneering groundbreaking solutions in cell therapy and regenerative medicine.

Access this on-demand recording today

Important Registration Note: We kindly suggest confirming in advance that your Zoom sign-in works and that your Zoom software is up to date. If you do not have a commercial Zoom account, please create a FREE account here.

We’re here to help you improve the efficacy of your cell therapies and invite you to follow us on social media for the latest updates.

What are you waiting for?

Attend the webinar and discover how it is possible to make transporting live cell therapies cost-efficient and less hazardous while increasing cell viability.

Register Today